Search Results - "Sendi, Hossein"
-
1
Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis
Published in Cancer research (Chicago, Ill.) (01-01-2022)“…Liver metastasis is a leading cause of cancer morbidity and mortality. Thus, there has been strong interest in the development of therapeutics that can…”
Get full text
Journal Article -
2
The role of liver microenvironment in hepatic metastasis
Published in Clinical and translational medicine (01-07-2019)“…Metastasis is still poorly understood and thus further research must be conducted to provide insight into the driving factors. Novel research has revealed the…”
Get full text
Journal Article -
3
Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis
Published in Hepatitis monthly (01-05-2012)“…The hepatic microRNA (miRNA), miR-122, is the most abundant miRNA within the liver, where it accounts for 70% of the total miRNA pool. It is known that…”
Get full text
Journal Article -
4
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling
Published in PloS one (19-07-2018)“…To investigate the role of miR-122 in the development and regression of non-alcoholic fatty liver disease (NAFLD) in vitro, we used multicellular 3D human…”
Get full text
Journal Article -
5
Hepatitis C, porphyria cutanea tarda and liver iron: an update
Published in Liver international (01-07-2012)“…Porphyria cutanea tarda (PCT) is the most common form of porphyria across the world. Unlike other forms of porphyria, which are inborn errors of metabolism,…”
Get full text
Journal Article -
6
Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome
Published in World journal of gastroenterology : WJG (21-10-2014)“…Hepatitis B virus(HBV) continues to be a major cause of morbidity and mortality worldwide. It is estimated that about 350 million people throughout the world…”
Get full text
Journal Article -
7
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV
Published in World journal of gastroenterology : WJG (07-04-2011)“…AIM: To determine the effect of Legalon-SIL (LS) on hepatitis C virus (HCV) core and NS5A expression and on heme oxygenase-1 (HMOX-1) and its transcriptional…”
Get full text
Journal Article -
8
Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection
Published in Hepatology research (01-03-2007)“…Aim: We tested associations between HFE mutations and hepatitis B virus (HBV) infection. We also explored measures of total body iron status and their…”
Get full text
Journal Article -
9
Abstract 5033: Targeted delivery of miR-122 into hepatocytes regresses liver metastasis
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Background: Metastatic tumors in the liver are 20 times more common than primary tumors and considered as a leading cause of mortality in several…”
Get full text
Journal Article -
10
Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo
Published in Small (Weinheim an der Bergstrasse, Germany) (01-02-2020)“…Hepatotoxicity is a key concern in the clinical translation of nanotherapeutics because preclinical studies have consistently shown that nanotherapeutics…”
Get full text
Journal Article -
11
Abstract 281: Culture of circulating tumor cells isolated from cancer patients with metastatic disease
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract OBJECTIVE: The purpose of this study is to investigate the feasibility of using decellularized tissue ECM to culture circulating tumor cells (CTCs)…”
Get full text
Journal Article -
12
CCR5 [Delta] 32 mutation is not prevalent in Iranians with chronic HBV infection
Published in Journal of medical virology (01-06-2013)“…CCR5 is an important chemokine receptor involved in the recruitment of specific anti-viral immune cells (e.g., NK cells and T cytotoxic cells) to the liver…”
Get full text
Journal Article -
13
CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection
Published in Journal of medical virology (01-06-2013)“…CCR5 is an important chemokine receptor involved in the recruitment of specific anti‐viral immune cells (e.g., NK cells and T cytotoxic cells) to the liver…”
Get full text
Journal Article -
14
HFE Gene Mutations in Cryptogenic Cirrhosis Patients
Published in Hepatitis monthly (01-01-2012)Get full text
Journal Article -
15
miR-122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA
Published in Liver international (01-04-2015)“…Background & Aims Analysis in silico suggests that occludin (OCLN), a key receptor for HCV, is a candidate target of miR‐122; the most abundant hepatic micro…”
Get full text
Journal Article -
16
Novel roles of microRNAs in hepatitis C
Published 01-01-2013“…Approximately, 170 million people are infected by hepatitis C virus (HCV) worldwide, and of these, nearly 85% will develop chronic hepatitis C (CHC). Despite…”
Get full text
Dissertation -
17
T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran
Published in Clinical laboratory (Heidelberg) (2012)“…Escape mutations potentially allow viruses to avoid detection and clearance by the host immune system and may represent a mechanism through which infections…”
Get more information
Journal Article -
18
M1806 Global miRNA Expression Profile of HCV Infected Human Hepatoma Cells
Published in Gastroenterology (New York, N.Y. 1943) (2009)Get full text
Journal Article -
19
CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA
Published in Journal of clinical virology (01-11-2009)“…Abstract Background Recent studies have suggested that Cytotoxic T lymphocytes (CTL) play a key role in eliminating hepatitis B virus (HBV). Objectives We…”
Get full text
Journal Article -
20